Macrophage-Expressed Micropeptide Smim30 Maintains Adipose Tissue Insulin Sensitivity and Safeguards Systemic

Yonghe Ma1, Yu Shi1, Kaiyuan Wu1

  • 1Laboratory of Obesity and Metabolic Diseases, Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Diabetes
|June 23, 2025
PubMed
Abstract

Insights

Small integral membrane protein 30 (Smim30) is a micropeptide that helps maintain insulin sensitivity and metabolic balance. This finding offers new therapeutic targets for metabolic disorders.

Area of Science:

  • Metabolic regulation and disease
  • Molecular mechanisms of homeostasis
  • Adipose tissue biology

Background:

  • Micropeptides (miPs) play emerging roles in cellular functions.
  • Small integral membrane protein 30 (Smim30) is expressed in adipose tissue macrophages.
  • Understanding Smim30's function is crucial for metabolic health.

Purpose of the Study:

  • To elucidate the role of Smim30 in metabolic regulation.
  • To investigate Smim30's impact on insulin sensitivity and systemic homeostasis.
  • To explore Smim30 as a potential biomarker and therapeutic target for metabolic disorders.

Main Methods:

  • Analysis of Smim30 expression in adipose tissue.
  • Assessment of insulin sensitivity in relevant models.
  • Investigation of macrophage-adipocyte communication pathways.
  • Evaluation of inflammatory responses modulated by Smim30.

Main Results:

  • Smim30 maintains insulin sensitivity.
  • Smim30 safeguards systemic metabolic homeostasis.
  • Smim30 modulates inflammatory responses and cell communication in adipose tissue.

Conclusions:

  • Smim30 is a key regulator of metabolic homeostasis.
  • Smim30 influences adipose tissue function and inflammation.
  • Smim30 presents a promising target for metabolic disease therapies.